Browsing Tag
Hunterbrook Capital
1 post
Hunterbrook Capital backs Achieve Life Sciences as FDA decision nears for cytisinicline
Hunterbrook Capital discloses a position in Achieve Life Sciences, citing cytisinicline’s potential to disrupt the smoking cessation market ahead of FDA review.